🚨New preprint from Legacy study @TheCrick & @UCLHresearch. ⏩biorxiv.org/content/10.1101/…
👉We asked: "What's a 'normal' COVID vaccine response?" 🤔
Turns out there's 2 kinds of 'normal' in healthy adults 🧐 — and this has implications for protection vs. future variants 🤒.🧵 1/n
I’m so grateful to have been awarded 2 Ideas Grants ($2.8M total). I’m really excited to grow my team and see what we achieve over the next 4 years.
Both projects are on Streptococcus pyogenes: 1) studying immune responses after infection, 2) developing a man therapy for iGAS.
Our annual report is here and what a year it’s been.
With your support we have achieved:
- £11.07 million spent on research, awareness and education, bringing our total research contribution over the last 10 years to £71m!
- 2,680 people joined #TeamKidney raising £1.3m for research
- 278 volunteers gave their time, their skills and their voice
- 56 new research grants were awarded
Sandra Currie, chief executive said: "We appreciate every donation that has enabled this, increasing our research investment over the year to almost £11 million. Every day I am reminded of the urgency of our work. Thank you for being part of making it count – we are so grateful for your ongoing support."
Read the full report here: bit.ly/3MNNKQi
[Image description: Professor Grazia is in a white lab coat and wearing blue latex gloves. She is smiling while holding a sample in a laboratory. She has short blonde hair and is wearing glasses. 'OUR ANNUAL REPORT. We are more essential than ever.' overlays the image.]
Now open!
Incl an IgA nephropathy project in my group.
We will fill in gaps in pathogenesis, aiming to better match new/upcoming drugs to each patient, and to find angles for next generation of treatments to remedy.
Please get in touch if you want more info.
New research: Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study
thelancet.com/journals/lanin…
100% out of my comfort zone, but an honour & a privilege to be asked to speak at #Drivingdiscoveries today.
Sharing my inner most thoughts & fears was hard, but essential to do so to give an understanding of why the research funded by @Kidney_Research is so imperative.
A special thank you to Melina, who captivated the room by sharing her story and highlighting what #KidneyResearch means to her and her son Charlie, who has nephronophthisis.
Hearing the emotion from her personal journey throughout the speech is a firm reminder that we are more than just research.
We are a community, advocates of people living with kidney disease, and we put patients at the heart of everything we do.
Thank you again Melina, it was an honour to have you with us today💜
@Formerlytigger
LFDs are of course great for lots of pathogens. But we tested 5 different commercial #Mpox *antibody* LFDs to see their utility for diagnostic/surveillance use, and they aren't great...from 0% to 56% sensitive!
thelancet.com/journals/lanin…
Incredibly excited for the launch of Pathoplexus, which I've spent quite a bit of time helping with over the past year. New, open-source, infrastructure for sharing viral sequence data!
📢 We're excited to introduce Pathoplexus, a specialized sequence database for human viral pathogens! 🌍 🧬
Launching with 4 viruses, Pathoplexus.org combines modern open-source software with transparent governance to improve global pathogen sequence sharing.
1/14
COVID cases are rising. For those needing lateral flow tests (LFTs), nhs.uk has launched a new pharmacy finder. This tool helps you locate pharmacies offering free LFTs if you're eligible for COVID-19 treatments.
Access the service at nhs.uk/COVIDtreatments.
Dinis Calado @DinisCalado investigates the interplay between Plasmodium falciparum, Epstein Barr Virus, and Burkitt’s lymphoma in mice. A step closer to understanding this aggressive cancer in malaria-endemic regions.
#WACCBIPis10#WRC2024#WRC24